Abstract
Extracellular vesicles (EVs) are nanosized membrane vesicles, released by many cell types, which are an ideal drug-delivery system for antitumor therapy. Exosomes, microparticles (MP), and apoptotic bodies are the three main types of EVs. MPs are EVs with size ranges between 100 and 1000 nm. Tumor cell-derived EVs (T-EVs) can serve as a safe and efficient vehicle to specific deliver chemotherapeutic drugs or oncolytic adenoviruses for tumor treatment. In this section, we describe how to prepare EVs for therapeutic use.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lemoinne S, Thabut D, Housset C, Moreau R, Valla D, Boulanger CM et al (2014) The emerging roles of microvesicles in liver diseases. Nat Rev Gastroenterol Hepatol 11:350–361
Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200:373–383
van Dommelen SM, Vader P, Lakhal S, Kooijmans SA, van Solinge WW, Wood MJ, Schiffelers RM (2012) Microvesicles and exosomes: opportunities for cell derived membrane vesicles in drug delivery. J Control Release 161:635–644
Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M et al (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470–1476
Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D et al (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes. Nat Med 4:594–600
Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H et al (2008) Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther 16:782–790
Tang K, Zhang Y, Zhang H, Xu P, Liu J, Ma J et al (2012) Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nat Commun 3:1–11
Ma J, Zhang Y, Tang K, Zhang H, Yin X, Li Y et al (2016) Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles. Cell Res 26:713–727
Ran L, Tan X, Li Y, Zhang H, Ma R, Ji T et al (2016) Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy. Biomaterials 89:56–66
Zhang H, Tang K, Zhang Y, Ma R, Ma J, Li Y et al (2015) Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS/STING signaling. Cancer Immunol Res 3:196–205
Acknowledgments
This work was supported by National Basic Research Program of China (2015CB932600), National Science Fund for Distinguished Young Scholars of China (81225021), and National Natural Science Foundation of China (81472735, 81472653, and 81530080). J. Liu and J. Ma contributed equally to this work.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Liu, J., Ma, J., Tang, K., Huang, B. (2017). Therapeutic Use of Tumor Cell-Derived Extracellular Vesicles. In: Kuo, W., Jia, S. (eds) Extracellular Vesicles. Methods in Molecular Biology, vol 1660. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7253-1_35
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7253-1_35
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7251-7
Online ISBN: 978-1-4939-7253-1
eBook Packages: Springer Protocols